Purchase Order 75D30124P19524
- Not listed
- This is a $4,470,182.84 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a provider of diagnostic information services. The contract is for "QUEST DIAGNOSTICS DATA" and has a period of performance through March 3, 2025. Quest Diagnostics has previously provided COVID-19 and other infectious disease testing services, as well as reference laboratory testing support, to various federal agencies...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Clinical Laboratories, Inc., a subsidiary of Quest Diagnostics Incorporated, for $92,922.00 in laboratory services. The contract is for the provision of comprehensive diagnostic testing solutions, including drug and alcohol testing, COVID-19 testing, and specialized diagnostic analyses, to support various federal healthcare, law enforcement, and workplace safety...
- This is a $74,393,160.50 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a large for-profit diagnostic information services provider. The contract is for COVID-19 genomic sequencing services and has a completion date of April 22, 2025. The contract is a firm-fixed-price type and does not utilize any set-aside designations. Quest Diagnostics has a strong track record of providing reference laboratory testing and diagnostic...
- This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
- This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...
- The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, for a Hepatitis C Prevalence Study. The $1,992,000.00 contract is to conduct a cross-sectional, multi-state assessment of viral hepatitis C prevalence through commercial laboratory testing of stored serum specimens, with a period of performance from September 2023 to September 2024. Quest Diagnostics has provided...
- This is a federal contract award to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, by the Centers for Disease Control and Prevention (CDC) for a Test Surge and Data Sharing Multiple Award Indefinite Delivery Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $3,636,702.00 and an ultimate completion date of September 26, 2029. The contract is for delivery orders and is a Firm Fixed Price type. The contract does not have a set-aside designation. Quest...
- Quest Diagnostics Incorporated has been awarded a firm fixed price, definitive contract valued at twenty-one million, seven hundred ninety-five thousand, twenty-six dollars by the Centers for Disease Control and Prevention to provide MASS-C serology services. Performance will take place in Secaucus, New Jersey with a completion date of December 11, 2023. No set-aside designation was used for this solicitation. As a leading provider of diagnostic information services, Quest Diagnostics will...
- The Centers for Disease Control and Prevention (CDC) awarded a $728,000 firm fixed price definitive contract to Quest Diagnostics Incorporated for de-identified specimen remnants to support the National Center for Immunization and Respiratory Diseases (NCIRD). As the prime contractor, Quest Diagnostics will provide de-identified biological specimens to NCIRD through April 2021. No subcontractors or set aside designations were indicated. NCIRD conducts public health surveillance, laboratory...
This is a $93,600 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a leading provider of clinical laboratory services. The contract is for the delivery of de-identified nasopharyngeal specimens, with a period of performance through August 13, 2026. This award does not have a set-aside designation. Quest Diagnostics has a long history of supporting federal agencies, including providing lab services for the CDC's public health research initiatives, the National Institute on Aging's HANDLS study, and the Department of Veterans Affairs' mobile blood collection services. The company has also assisted with COVID-19 response efforts by supplying lab supplies and specimens to the CDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $46.8k | 8/8/25 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 4/22/25 | |
| Not listed | Not listed | $46.8k | 8/13/24 |